empower semaglutide Wellness empower pharmacy semaglutide dosage Semaglutide

95% medication adherence in the first month 84% of prescribed patients engage with in-app content 56% use Med Tracker (where side effects can also be tracked) 56% engage in meal logging, with an average of 35 meals logged in the first month Patients log weight 1-2 times per week, on average, over the first 8 weeks of treatment Patients use Noom Move workouts an average of 6.9 times in the first month 45% engage with side-effect support in Nooms Success Kit Noom appreciates the potential of the new PDURS framework because it provides a way to put a software product on the drug label in an evidence-based way

Health authorities have warned that some compounded GLP-1 products may contain incorrect doses, different chemical formulations, or additional ingredients whose safety and effectiveness have not been established

Comment on Kom et al

Patients taking insulin or sulfonylureas concurrently should monitor blood glucose closely, as dose adjustments of these medications may be necessary to prevent hypoglycemia

Contrave is not a controlled substance

GLP-1 receptor agonists can influence acid reflux symptoms, but the relationship is complex and varies significantly by individual